The ERA Consulting Group and BioTechLogic have joined forces to found US Biologic Regulatory Services LLC (US-BRS). This joint venture company will extend, and bridge, the services of both parent organizations, offering clients high quality regulatory affairs support, particularly relating to FDA interactions and submissions, and to preclinical and clinical development strategies for biotech products and other biologics and drugs, in the USA. Furthermore, US-BRS will benefit from the resources of the parent companies, in particular our expertise and track record in the field of manufacturing and control of biologics.

Responsibility for ERA’s current projects in the USA will now be assumed by US-BRS, therefore offering existing as well as future clients an expanded service, of far wider scope, than was possible in the past. The ERA Consulting Group continues its own independent services, as before, in the European and Australasian regions. Enquiries relating to the services of US-BRS can be directed through either parent organization or by visiting: www.us-brs.com